MPTP- but not methamphetamine-induced parkinsonism extends to catecholamine neurons in the gut

Annals of the New York Academy of Sciences

Volumn 1139, Issue , 2008, Pages 345-349

  Natale, Gianfranco ^a   Kastsiuchenka, Olga ^a   Pasquali, Livia ^a   Ruggieri, Stefano ^b   Paparelli, Antonio ^a   Fornai, Francesco ^a,b  

^a UNIVERSITY OF PISA   (Italy)

^b IRCCS NEUROMED   (Italy)

Author keywords

Gut; METH; Mouse; MPTP; Parkinson's disease; Tyrosine hydroxylase

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CATECHOLAMINE; METHAMPHETAMINE; TYROSINE 3 MONOOXYGENASE;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; AUTONOMIC NERVE; CATECHOLAMINE NERVE CELL; CONFERENCE PAPER; CONTROLLED STUDY; MALE; MOUSE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PARKINSONISM;

MUS;

EID: 53549128961     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1432.015     Document Type: Conference Paper

References (18)

1. Iacovelli, L. et al. 2006. The neurotoxicity of amphetamines: bridging drugs of abuse and neurodegenerative disorders. Exp. Neurol. 201 : 24 31.
2. Fornai, F. et al. 2004. Methamphetamine produces neuronal inclusions in the nigrostriatal system and in PC12 cells. J. Neurochem. 88 : 114 123.
3. Fornai, F. et al. 2004. DNA damage and ubiquinated neuronal inclusions in the substantia nigra and striatum of mice following MDMA (ecstasy). Psychopharmacology 173 : 353 363.
4. Edwards, L.L. et al. 1991. Gastrointestinal symptoms in Parkinson's disease. Mov. Disord. 6 : 151 156.
5. Jost, W.H. 1997. Gastrointestinal motility problems in patients with Parkinson's disease: effects of antiparkinsonian treatment and guidelines for management. Drugs Aging 10 : 249 258.
6. Pfeiffer, R.F. 2003. Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol. 2 : 107 16.
7. Singaram, C. et al. 1995. Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation. Lancet 346 : 861 864.
8. Wakabayashi, K. et al. 1988. The presence of Lewy bodies in Auerbach's and Meissner's plexuses. Acta Neuropathol. 76 : 217 221.
9. Doong, M.L. et al. 1998. Inhibition of gastric emptying and intestinal transit by amphetamine through a mechanism involving an increased secretion of CCK in male rats. Br. J. Pharmacol. 124 : 1123 1130.
10. Szabo, S. et al. 1985. Duodenal ulcer induced by MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropiridine). Proc. Soc. Exp. Biol. Med. 180 : 567 571.
11. Eaker, E.Y. et al. 1987. Chronic alterations in jejunal myoelectric activity in rats due to MPTP. Am. J. Physiol. 253 : G809 G815.
12. Hanani, M. 1990. Rapid effects of MPTP in the mouse colon. Eur. J. Pharmacol. 175 : 273 277.
13. Haskel, Y. & M. Hanani. 1994. Inhibition of gastrointestinal motility by MPTP via adrenergic and dopaminergic mechanisms. Dig. Dis. Sci. 39 : 2364 2367.
14. Eaker, E.Y. et al. 1988. Dopamine and norepinephrine in the gastrointestinal tract of mice and the effects of neurotoxins. J. Pharmacol. Exp. Ther. 244 : 438 442.
15. McKenna, D.J. & S.J. Peroutka. 1990. Neuro-chemistry and neurotoxicity of 3,4-methylenedioxy-methamphetamine (MDMA, "ecstasy"). J. Neurochem. 54 : 14 22.
16. Johnson, T.D. & M.M. Berenson. 1991. Methamphetamine-induced ischemic colitis. J. Clin. Gastroenterol. 13 : 687 689.
17. Herr, R.D. & E.M. Caravati. 1991. Acute transient ischemic colitis after oral methamphetamine ingestion. Am. J. Emerg. Med. 9 : 406 409.
18. Brannan, T.A. et al. 2004. Methamphetamine-associated shock with intestinal infarction. MedGenMed. 6 : 6.